MedPath
NMPA Approval

Epinastine Hydrochloride Granules

国药准字H20223747

October 11, 2022

Drug Information

盐酸依匹斯汀颗粒

颗粒剂

5mg

化学药品

October 11, 2022

Company Information

Applicant Company

广州市经济技术开发区东区东博路6号

Manufacturing Company

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸依匹斯汀颗粒 - NMPA 批准文号 | MedPath